Pharmaceuticals stocks in India
Every listed pharmaceuticals company on NSE and BSE in our database, largest first, with its valuation, profitability, latest quarterly growth, one-year return and next results date.
There are 228 listed companies in the Pharmaceuticals industry on NSE and BSE in our database, 130 of them with full financials.
The largest by market capitalisation are Sun Pharmaceutical Industries Limited (₹421,803 Cr), Divi's Laboratories Limited (₹243,222 Cr), Torrent Pharmaceuticals Limited (₹175,551 Cr).
Among the 101 companies worth more than ₹500 Cr, the median P/E of the profitable ones is 34.9 and the median return on equity is 12.6%.
Fastest sales growth in the latest quarter (year on year, above ₹500 Cr): Sai Parenterals +435%, Sun Pharma +314%, Anlon Healthcare +163%.
Next to report results: Torrent Pharmaceuticals on 23 Oct, Dr. Reddy's on 23 Oct, Sakar Healthcare on 23 Oct.
Pharmaceuticals companies by market cap
| # | Company | Market cap | P/E | ROE | Qtr sales YoY | Qtr profit YoY | Return 1Y | Next results |
|---|---|---|---|---|---|---|---|---|
| 1 | Sun Pharmaceutical Industries LimitedSUNPHARMA | ₹421,803 Cr | 34.85 | 14.5% | +10.5% | +27.0% | +6.2% | 30 Oct |
| 2 | Divi's Laboratories LimitedDIVISLAB | ₹243,222 Cr | 83.15 | 17.5% | +27.8% | +65.5% | +39.4% | 07 Nov |
| 3 | Torrent Pharmaceuticals LimitedTORNTPHARM | ₹175,551 Cr | 81.42 | 25.7% | +54.8% | +3.3% | +30.6% | 23 Oct |
| 4 | Zydus Lifesciences LimitedZYDUSLIFE | ₹113,217 Cr | 22.33 | 18.7% | +16.2% | +14.5% | +16.1% | 04 Nov |
| 5 | Laurus Labs LimitedLAURUSLABS | ₹108,198 Cr | 99.23 | 20.6% | +29.1% | +123.9% | +128.8% | 29 Oct |
| 6 | Cipla LimitedCIPLA | ₹107,520 Cr | 32.04 | 9.7% | +2.3% | -39.2% | -14.6% | 27 Oct |
| 7 | Dr. Reddy's Laboratories LimitedDRREDDY | ₹103,207 Cr | 31.54 | 8.6% | -5.6% | -69.2% | +0.5% | 23 Oct |
| 8 | Mankind Pharma LimitedMANKIND | ₹93,993 Cr | 45.47 | 12.7% | +12.9% | +29.1% | -7.0% | 26 Oct |
| 9 | Aurobindo Pharma LimitedAUROPHARMA | ₹92,688 Cr | 24.98 | 9.8% | +16.3% | +25.2% | +45.3% | — |
| 10 | Lupin LimitedLUPIN | ₹87,886 Cr | 16.41 | 23.9% | +31.9% | +87.8% | -0.9% | 03 Nov |
| 11 | Glenmark Pharmaceuticals LimitedGLENMARK | ₹62,047 Cr | 34.52 | 17.1% | +23.1% | +927.9% | +16.1% | — |
| 12 | Alkem Laboratories LimitedALKEM | ₹59,944 Cr | 27.41 | 15.8% | +10.9% | -21.6% | -9.9% | — |
| 13 | Biocon LimitedBIOCON | ₹54,095 Cr | 129.79 | 1.2% | +10.0% | +53.4% | -7.3% | — |
| 14 | Abbott IndiaABBOTINDIA | ₹53,888 Cr | 33.36 | 33.8% | +4.4% | +17.2% | -15.0% | — |
| 15 | IPCA Laboratories LimitedIPCALAB | ₹48,293 Cr | 35.03 | 17.1% | +20.8% | +82.2% | +46.7% | 05 Nov |
| 16 | Gland Pharma LimitedGLAND | ₹47,035 Cr | 45.77 | 9.9% | +22.3% | +96.7% | +47.2% | 06 Nov |
| 17 | GlaxoSmithKline Pharmaceuticals LimitedGLAXO | ₹41,228 Cr | 38.61 | 47.1% | +16.6% | +15.7% | -11.0% | 03 Nov |
| 18 | Ajanta Pharma LimitedAJANTPHARM | ₹40,869 Cr | 36.00 | 25.1% | +24.8% | +30.9% | +35.7% | 30 Oct |
| 19 | Emcure Pharmaceuticals LimitedEMCURE | ₹33,818 Cr | 33.19 | 20.6% | +22.8% | +36.0% | +33.1% | 03 Nov |
| 20 | Wockhardt LimitedWOCKPHARMA | ₹30,150 Cr | 85.41 | 7.1% | +25.9% | +199.1% | +36.9% | — |
| 21 | Sai Life Sciences LimitedSAILIFE | ₹29,648 Cr | 86.45 | 13.8% | +3.8% | +18.2% | +62.6% | 05 Nov |
| 22 | Acutaas Chemicals LimitedACUTAAS | ₹26,324 Cr | 68.05 | — | +59.1% | +70.4% | +107.6% | 27 Oct |
| 23 | Piramal Pharma LimitedPPLPHARMA | ₹25,837 Cr | 104.59 | 3.0% | +17.4% | -161.3% | +0.8% | 27 Oct |
| 24 | Neuland Laboratories LimitedNEULANDLAB | ₹24,293 Cr | 66.60 | 19.5% | +136.3% | +666.0% | +17.6% | 03 Nov |
| 25 | Rubicon Research LimitedRUBICON | ₹23,717 Cr | 82.23 | — | +51.8% | +97.2% | — | — |
| 26 | Granules India LimitedGRANULES | ₹20,245 Cr | 30.56 | 13.0% | +22.0% | +59.3% | +43.6% | — |
| 27 | Cohance Lifesciences LimitedCOHANCE | ₹17,364 Cr | 298.25 | — | -23.1% | -197.4% | -47.8% | — |
| 28 | Caplin Point Laboratories LimitedCAPLIPOINT | ₹17,096 Cr | 25.20 | 18.9% | +19.6% | +18.8% | +11.4% | — |
| 29 | Pfizer LimitedPFIZER | ₹16,876 Cr | 22.96 | 17.5% | +8.3% | +6.2% | -30.9% | — |
| 30 | Shilpa Medicare LimitedSHILPAMED | ₹16,836 Cr | 56.60 | 11.5% | +44.9% | +115.2% | +141.4% | — |
| 31 | Onesource Specialty Pharma LimitedONESOURCE | ₹15,800 Cr | — | -0.8% | +37.3% | +0.7% | -25.4% | 27 Oct |
| 32 | Alivus Life Sciences LimitedALIVUS | ₹15,580 Cr | 25.83 | 18.1% | +6.4% | +31.2% | +35.8% | 29 Oct |
| 33 | Eris Lifesciences LimitedERIS | ₹15,555 Cr | 23.37 | 17.1% | +13.0% | +14.6% | -29.2% | 26 Oct |
| 34 | Alembic Pharmaceuticals LimitedAPLLTD | ₹15,357 Cr | 22.20 | 12.2% | +25.7% | +12.7% | -14.9% | — |
| 35 | AstraZeneca Pharma India LimitedASTRAZEN | ₹15,252 Cr | 89.97 | 19.4% | +29.7% | -32.1% | -33.3% | — |
| 36 | Jubilant Pharmova LimitedJUBLPHARMA | ₹14,765 Cr | 42.02 | 5.0% | +1385.3% | +3217.6% | -13.4% | — |
| 37 | Natco Pharma LimitedNATCOPHARM | ₹14,320 Cr | 13.22 | 11.7% | -44.7% | -55.5% | -4.3% | — |
| 38 | Marksans Pharma LimitedMARKSANS | ₹13,343 Cr | 25.59 | 17.2% | +35.6% | +174.8% | +62.9% | 04 Nov |
| 39 | Concord Biotech LimitedCONCORDBIO | ₹13,294 Cr | 48.74 | 13.5% | +26.2% | +31.0% | -15.7% | 27 Oct |
| 40 | CORONA Remedies LimitedCORONA | ₹12,486 Cr | 62.92 | — | +21.7% | +30.7% | — | 30 Oct |
| 41 | Sudeep Pharma LimitedSUDEEPPHRM | ₹10,866 Cr | 58.94 | — | +26.6% | +30.9% | — | 28 Oct |
| 42 | Akums Drugs and Pharmaceuticals LimitedAKUMS | ₹10,414 Cr | 35.58 | 8.8% | +13.9% | +56.1% | +48.0% | — |
| 43 | Strides Pharma Science LimitedSTAR | ₹9,203 Cr | 23.69 | 12.5% | +11.2% | +50.0% | +23.4% | — |
| 44 | Viyash Scientific LimitedVIYASH | ₹9,180 Cr | 67.70 | 4.7% | +128.9% | +560.0% | — | — |
| 45 | Blue Jet Healthcare LimitedBLUEJET | ₹8,460 Cr | — | — | -17.4% | -14.2% | -26.3% | — |
| 46 | Procter & Gamble Health LimitedPGHL | ₹8,403 Cr | 23.46 | 68.2% | +7.3% | +45.7% | -18.0% | 02 Nov |
| 47 | Symbiotec Pharmalab LimitedSYMBIOTEC | ₹7,597 Cr | — | — | +7.5% | -53.1% | — | — |
| 48 | Sanofi Consumer Healthcare India LimitedSANOFICONR | ₹7,525 Cr | 28.31 | — | +6.7% | +12.8% | -30.1% | 28 Oct |
| 49 | Aarti Pharmalabs LimitedAARTIPHARM | ₹7,516 Cr | 35.27 | 10.0% | +38.7% | +53.8% | -0.9% | 28 Oct |
| 50 | Bliss GVS Pharma LimitedBLISSGVS | ₹6,834 Cr | 48.07 | 11.9% | +37.6% | +15.8% | +324.6% | 29 Oct |
| 51 | Supriya Lifescience LimitedSUPRIYA | ₹6,730 Cr | 33.97 | 16.5% | +30.8% | -30.9% | +16.1% | — |
| 52 | Sanofi India LimitedSANOFI | ₹6,520 Cr | 20.09 | — | +7.8% | +19.3% | -39.7% | 29 Oct |
| 53 | Morepen Laboratories LimitedMOREPENLAB | ₹6,448 Cr | 45.60 | 11.3% | +34.1% | +394.0% | +144.7% | 27 Oct |
| 54 | Innova Captab LimitedINNOVACAP | ₹5,702 Cr | 11.47 | 45.6% | +33.9% | +42.3% | +20.5% | — |
| 55 | Sun Pharma Advanced Research Company LimitedSPARC | ₹5,617 Cr | 3.55 | 118.4% | +314.1% | +59.9% | +31.9% | 02 Nov |
| 56 | FDC LimitedFDC | ₹5,543 Cr | 19.02 | 11.7% | +3.0% | +9.5% | -22.0% | 27 Oct |
| 57 | Senores Pharmaceuticals LimitedSENORES | ₹5,538 Cr | 42.23 | 14.0% | +30.6% | +43.8% | +67.5% | 29 Oct |
| 58 | IOL Chemicals and Pharmaceuticals LimitedIOLCP | ₹5,030 Cr | 29.95 | 9.3% | +37.1% | +89.8% | +75.6% | — |
| 59 | Gujarat Themis Biosyn LimitedGUJTHEM | ₹4,600 Cr | 95.69 | — | +21.6% | +23.0% | -17.9% | — |
| 60 | RPG Life Sciences LimitedRPGLIFE | ₹4,598 Cr | 38.35 | 19.8% | +15.8% | +17.0% | +21.4% | 29 Oct |
P/E "n/m" means the company made a loss over the last four quarters. Quarterly growth compares the latest quarter with the same quarter a year earlier. "—" means the figure is not available.
More pharmaceuticals companies
Upcoming pharmaceuticals results
Frequently asked questions
Which are the largest pharmaceuticals stocks in India?
By market capitalisation: Sun Pharmaceutical Industries Limited (₹421,803 Cr), Divi's Laboratories Limited (₹243,222 Cr), Torrent Pharmaceuticals Limited (₹175,551 Cr), Zydus Lifesciences Limited (₹113,217 Cr), Laurus Labs Limited (₹108,198 Cr).
How many pharmaceuticals companies are listed in India?
228 companies listed on NSE and BSE are classified in the Pharmaceuticals industry on this page, which merges the exchanges' and data vendors' labels for the same business.
What is the average P/E of pharmaceuticals stocks?
The median P/E of profitable pharmaceuticals companies worth more than ₹500 Cr is 34.9, based on trailing-twelve-month profit and the latest close.
When do pharmaceuticals companies announce their results?
Upcoming board meetings for results: Torrent Pharmaceuticals Limited on 23 Oct 2026; Dr. Reddy's Laboratories Limited on 23 Oct 2026; Sakar Healthcare Limited on 23 Oct 2026; Amwill Health Care Ltd on 23 Oct 2026; Sat Kartar Life Limited on 24 Oct 2026.